Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to AMD

NCT00658619 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00658619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00658619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to AMD
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2008
Completion date
April 8, 2011
Enrollment
119 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration